Sponsor

Carmot Therapeutics, Inc.

Clinical research sponsor

Published trials8

Recruiting shown0

Roles2

SourceClinicalTrials.gov

Clinical trials

8 shown

A Study of Enicepatide (CT-388) in Participants Who Are Overweight or Obese With Type 2 Diabetes MellitusNCT06628362 · lead sponsor · 2024-11-21

COMPLETED

A Study of Enicepatide (CT-388) in Participants With Obesity or Overweight With at Least One Weight-Related ComorbidityNCT06525935 · lead sponsor · 2024-08-16

COMPLETED

A Study of CT-868 in Type 1 Diabetes MellitusNCT06062069 · lead sponsor · 2023-10-19

COMPLETED

A Study to Assess the Effects of CT-868 Treatment on Glucose Homeostasis in Participants with Type 1 DiabetesNCT05794581 · lead sponsor · 2023-03-21

COMPLETED

A Study of CT-868 in Overweight and Obese Participants With Type 2 Diabetes MellitusNCT05110846 · lead sponsor · 2022-02-22

COMPLETED

A Study to Assess CT-868 and the Relationship Between Insulin Secretory Response and Ambient Blood GlucoseNCT04973111 · lead sponsor · 2021-07-16

COMPLETED

A Study of CT-388 in Otherwise Healthy Overweight and Obese Adults and Patients With Type 2 Diabetes MellitusNCT04838405 · lead sponsor · 2021-04-29

COMPLETED

Phase 1 Study of CT-996 in Overweight/Obese Participants and Patients With Type 2 Diabetes MellitusNCT05814107 · collaborator · 2023-05-09

COMPLETED

Sponsor roles

lead sponsor7

collaborator1

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.